Changes in fasting plasma glucose and subclinical atherosclerosis: A cohort study from VIPVIZA trial.
Salvador D Jr, Liv P, Norberg M, Pahud de Mortanges A, Saner H, Glisic M, Nicoll R, Muka T, Nyman E, Bano A, Näslund U.
Salvador D Jr, et al. Among authors: muka t.
Atherosclerosis. 2024 Jul;394:117326. doi: 10.1016/j.atherosclerosis.2023.117326. Epub 2023 Oct 17.
Atherosclerosis. 2024.
PMID: 37932189
Clinical Trial.